{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T04:42:19Z","timestamp":1778042539563,"version":"3.51.4"},"reference-count":61,"publisher":"Oxford University Press (OUP)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1093\/carcin\/bgs263","type":"journal-article","created":{"date-parts":[[2012,8,8]],"date-time":"2012-08-08T04:59:09Z","timestamp":1344401949000},"page":"2283-2292","source":"Crossref","is-referenced-by-count":25,"title":["Pharmacological targeting of mammalian target of rapamycin inhibits ovarian granulosa cell tumor growth"],"prefix":"10.1093","volume":"33","author":[{"given":"Charl\u00e8ne","family":"Rico","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie-No\u00eblle","family":"Lagu\u00eb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pavine","family":"Lef\u00e8vre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mayra","family":"Tsoi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aurore","family":"Dodelet-Devillers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vikas","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evelyne","family":"Lapointe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maril\u00e8ne","family":"Paquet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie-\u00c8ve","family":"Nadeau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Derek","family":"Boerboom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2012,7,27]]},"reference":[{"key":"key\n\t\t\t\t20170520233429_CIT0001","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1200\/JCO.2003.10.019","article-title":"Granulosa cell tumor of the ovary","volume":"21","author":"Schumer","year":"2003","journal-title":"J. Clin. Oncol."},{"key":"key\n\t\t\t\t20170520233429_CIT0002","volume-title":"Pathology of Domestic Animals","author":"Jubb","year":"1993"},{"key":"key\n\t\t\t\t20170520233429_CIT0003","first-page":"435","article-title":"Control of differentiation, transformation, and apoptosis in granulosa cells by oncogenes, oncoviruses, and tumor suppressor genes","volume":"18","author":"Amsterdam","year":"1997","journal-title":"Endocr. Rev."},{"key":"key\n\t\t\t\t20170520233429_CIT0004","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S1701-2163(16)30464-9","article-title":"Granulosa cell tumour: a recurrence 40 years after initial diagnosis.","volume":"27","author":"East","year":"2005","journal-title":"J. Obstet. Gynaecol. Can."},{"key":"key\n\t\t\t\t20170520233429_CIT0005","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1097\/01.pgp.0000228143.52054.46","article-title":"Clinical and pathological predictive factors in women with adult-type granulosa cell tumor of the ovary.","volume":"26","author":"Villella","year":"2007","journal-title":"Int. J. Gynecol. Pathol."},{"key":"key\n\t\t\t\t20170520233429_CIT0006","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1210\/er.2011-0014","article-title":"Molecular pathogenesis of granulosa cell tumors of the ovary","volume":"33","author":"Jamieson","year":"2012","journal-title":"Endocr. Rev."},{"key":"key\n\t\t\t\t20170520233429_CIT0007","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s12672-011-0069-3","article-title":"Nuclear receptor profiling of ovarian granulosa cell tumors.","volume":"2","author":"Alexiadis","year":"2011","journal-title":"Horm. Cancer"},{"key":"key\n\t\t\t\t20170520233429_CIT0008","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.ygyno.2011.05.008","article-title":"FOXL2 C402G mutation detection using MALDI-TOF-MS in DNA extracted from Israeli granulosa cell tumors.","volume":"122","author":"Gershon","year":"2011","journal-title":"Gynecol. Oncol."},{"key":"key\n\t\t\t\t20170520233429_CIT0009","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1038\/onc.2010.541","article-title":"Differential apoptotic activities of wild-type FOXL2 and the adult-type granulosa cell tumor-associated mutant FOXL2 (C134W).","volume":"30","author":"Kim","year":"2011","journal-title":"Oncogene"},{"key":"key\n\t\t\t\t20170520233429_CIT0010","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/path.2688","article-title":"Mutational analysis of FOXL2 codon 134 in granulosa cell tumour of ovary and other human cancers.","volume":"221","author":"Kim","year":"2010","journal-title":"J. Pathol."},{"key":"key\n\t\t\t\t20170520233429_CIT0011","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1056\/NEJMoa0902542","article-title":"Mutation of FOXL2 in granulosa-cell tumors of the ovary.","volume":"360","author":"Shah","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"key\n\t\t\t\t20170520233429_CIT0012","first-page":"1020","article-title":"A mutation in the follicle-stimulating hormone receptor occurs frequently in human ovarian sex cord tumors.","volume":"82","author":"Kotlar","year":"1997","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"key\n\t\t\t\t20170520233429_CIT0013","first-page":"274","article-title":"No evidence of a role for mutations or polymorphisms of the follicle-stimulating hormone receptor in ovarian granulosa cell tumors.","volume":"83","author":"Fuller","year":"1998","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"key\n\t\t\t\t20170520233429_CIT0014","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/S0015-0282(00)01565-X","article-title":"No evidence of somatic activating mutations on gonadotropin receptor genes in sex cord stromal tumors.","volume":"74","author":"Giacaglia","year":"2000","journal-title":"Fertil. Steril."},{"key":"key\n\t\t\t\t20170520233429_CIT0015","doi-asserted-by":"crossref","first-page":"3852","DOI":"10.1210\/jcem.84.10.6021-1","article-title":"Comment on analysis of mutations in genes of the follicle-stimulating hormone receptor in ovarian granulosa cell tumors.","volume":"84","author":"Hussein","year":"1999","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"key\n\t\t\t\t20170520233429_CIT0016","first-page":"2074","article-title":"Activating mutation of the stimulatory G protein (gsp) as a putative cause of ovarian and testicular human stromal Leydig cell tumors.","volume":"83","author":"Fragoso","year":"1998","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"key\n\t\t\t\t20170520233429_CIT0017","first-page":"2233","article-title":"Analysis of mutations in genes of the follicle-stimulating hormone receptor signaling pathway in ovarian granulosa cell tumors.","volume":"84","author":"Ligtenberg","year":"1999","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"key\n\t\t\t\t20170520233429_CIT0018","first-page":"4159","article-title":"Absence of the previously reported G protein oncogene (gip2) in ovarian granulosa cell tumors.","volume":"81","author":"Shen","year":"1996","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"key\n\t\t\t\t20170520233429_CIT0019","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1210\/edrv-15-6-725","article-title":"Hormonal control of gene expression in the ovary.","volume":"15","author":"Richards","year":"1994","journal-title":"Endocr. Rev."},{"key":"key\n\t\t\t\t20170520233429_CIT0020","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1016\/j.cellsig.2006.02.011","article-title":"FSH signaling pathways in immature granulosa cells that regulate target gene expression: branching out from protein kinase A","volume":"18","author":"Hunzicker-Dunn","year":"2006","journal-title":"Cell. Signal."},{"key":"key\n\t\t\t\t20170520233429_CIT0021","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1210\/me.2004-0487","article-title":"Follicle-stimulating hormone induction of ovarian insulin-like growth factor-binding protein-3 transcription requires a TATA box-binding protein and the protein kinase A and phosphatidylinositol-3 kinase pathways.","volume":"19","author":"Ongeri","year":"2005","journal-title":"Mol. Endocrinol."},{"key":"key\n\t\t\t\t20170520233429_CIT0022","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1210\/me.2007-0020","article-title":"Follicle-stimulating hormone induces multiple signaling cascades: evidence that activation of Rous sarcoma oncogene, RAS, and the epidermal growth factor receptor are critical for granulosa cell differentiation.","volume":"21","author":"Wayne","year":"2007","journal-title":"Mol. Endocrinol."},{"key":"key\n\t\t\t\t20170520233429_CIT0023","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1111\/IGC.0b013e3181a1cdfd","article-title":"Expression status and mutational analysis of the PTEN and P13K subunit genes in ovarian granulosa cell tumors.","volume":"19","author":"Bittinger","year":"2009","journal-title":"Int. J. Gynecol. Cancer"},{"key":"key\n\t\t\t\t20170520233429_CIT0024","doi-asserted-by":"crossref","first-page":"19431","DOI":"10.1074\/jbc.M401235200","article-title":"Follicle-stimulating hormone activation of hypoxia-inducible factor-1 by the phosphatidylinositol 3-kinase\/AKT\/Ras homolog enriched in brain (Rheb)\/mammalian target of rapamycin (mTOR) pathway is necessary for induction of select protein markers of follicular differentiation.","volume":"279","author":"Alam","year":"2004","journal-title":"J. Biol. Chem."},{"key":"key\n\t\t\t\t20170520233429_CIT0025","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1038\/bjc.2012.36","article-title":"Aberrant activation of the mTOR pathway and anti-tumour effect of everolimus on oesophageal squamous cell carcinoma","volume":"106","author":"Hirashima","year":"2010","journal-title":"Br. J. Cancer"},{"key":"key\n\t\t\t\t20170520233429_CIT0026","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.canlet.2009.09.015","article-title":"mTOR inhibitor rapamycin alone or combined with cisplatin inhibits growth of esophageal squamous cell carcinoma in nude mice.","volume":"290","author":"Hou","year":"2010","journal-title":"Cancer Lett."},{"key":"key\n\t\t\t\t20170520233429_CIT0027","doi-asserted-by":"crossref","first-page":"4795","DOI":"10.1158\/1078-0432.CCR-07-0738","article-title":"Activated mammalian target of rapamycin is an adverse prognostic factor in patients with biliary tract adenocarcinoma.","volume":"13","author":"Herberger","year":"2007","journal-title":"Clin. Cancer Res."},{"key":"key\n\t\t\t\t20170520233429_CIT0028","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1002\/cncr.24239","article-title":"Targeting mTOR in renal cell carcinoma","volume":"115","author":"Hudes","year":"2009","journal-title":"Cancer"},{"key":"key\n\t\t\t\t20170520233429_CIT0029","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1093\/carcin\/bgn186","article-title":"Synergistic effects of Pten loss and WNT\/CTNNB1 signaling pathway activation in ovarian granulosa cell tumor development and progression.","volume":"29","author":"Lagu\u00eb","year":"2008","journal-title":"Carcinogenesis"},{"key":"key\n\t\t\t\t20170520233429_CIT0030","doi-asserted-by":"crossref","first-page":"9206","DOI":"10.1158\/0008-5472.CAN-05-1024","article-title":"Misregulated Wnt\/beta-catenin signaling leads to ovarian granulosa cell tumor development.","volume":"65","author":"Boerboom","year":"2005","journal-title":"Cancer Res."},{"key":"key\n\t\t\t\t20170520233429_CIT0031","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1126\/science.1065518","article-title":"Negative regulation of neural stem\/progenitor cell proliferation by the Pten tumor suppressor gene in vivo .","volume":"294","author":"Groszer","year":"2001","journal-title":"Science"},{"key":"key\n\t\t\t\t20170520233429_CIT0032","doi-asserted-by":"crossref","first-page":"5931","DOI":"10.1093\/emboj\/18.21.5931","article-title":"Intestinal polyposis in mice with a dominant stable mutation of the beta-catenin gene.","volume":"18","author":"Harada","year":"1999","journal-title":"EMBO J."},{"key":"key\n\t\t\t\t20170520233429_CIT0033","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1038\/ng1003","article-title":"Requirement of Bmpr1a for M\u00fcllerian duct regression during male sexual development.","volume":"32","author":"Jamin","year":"2002","journal-title":"Nat. Genet."},{"key":"key\n\t\t\t\t20170520233429_CIT0034","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1210\/me.2003-0301","article-title":"Granulosa cell-specific inactivation of follistatin causes female fertility defects.","volume":"18","author":"Jorgez","year":"2004","journal-title":"Mol. Endocrinol."},{"key":"key\n\t\t\t\t20170520233429_CIT0035","first-page":"553","article-title":"A mouse surgical model for metastatic ovarian granulosa cell tumor.","volume":"59","author":"Nadeau","year":"2009","journal-title":"Comp. Med."},{"key":"key\n\t\t\t\t20170520233429_CIT0036","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1210\/endo-95-3-818","article-title":"Granulosa cell maturation in the rat: increased binding of human chorionic gonadotropin following treatment with follicle-stimulating hormone in vivo .","volume":"95","author":"Zeleznik","year":"1974","journal-title":"Endocrinology"},{"key":"key\n\t\t\t\t20170520233429_CIT0037","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.ctrv.2006.10.007","article-title":"Systemic therapy in metastatic or recurrent endometrial cancer.","volume":"33","author":"Pectasides","year":"2007","journal-title":"Cancer Treat. Rev."},{"key":"key\n\t\t\t\t20170520233429_CIT0038","doi-asserted-by":"crossref","first-page":"25485","DOI":"10.1074\/jbc.M501707200","article-title":"Phosphorylation of mammalian target of rapamycin (mTOR) at Ser-2448 is mediated by p70S6 kinase","volume":"280","author":"Chiang","year":"2005","journal-title":"J. Biol. Chem."},{"key":"key\n\t\t\t\t20170520233429_CIT0039","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/BJ20110892","article-title":"Regulation and function of ribosomal protein S6 kinase (S6K) within mTOR signalling networks.","volume":"441","author":"Magnuson","year":"2012","journal-title":"Biochem. J."},{"key":"key\n\t\t\t\t20170520233429_CIT0040","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1042\/BST20110682","article-title":"Roles of the mammalian target of rapamycin, mTOR, in controlling ribosome biogenesis and protein synthesis.","volume":"40","author":"Iadevaia","year":"2012","journal-title":"Biochem. Soc. Trans."},{"key":"key\n\t\t\t\t20170520233429_CIT0041","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/978-1-61779-430-8_10","article-title":"Evaluation of mTOR-regulated mRNA translation.","volume":"821","author":"Iadevaia","year":"2012","journal-title":"Methods Mol. Biol."},{"key":"key\n\t\t\t\t20170520233429_CIT0042","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1038\/nrc2501","article-title":"Hypoxia signalling through mTOR and the unfolded protein response in cancer","volume":"8","author":"Wouters","year":"2008","journal-title":"Nat. Rev. Cancer"},{"key":"key\n\t\t\t\t20170520233429_CIT0043","doi-asserted-by":"crossref","first-page":"2748","DOI":"10.2337\/diabetes.53.11.2748","article-title":"regulation of peroxisome proliferator-activated receptor-gamma activity by mammalian target of rapamycin and amino acids in adipogenesis.","volume":"53","author":"Kim","year":"2004","journal-title":"Diabetes"},{"key":"key\n\t\t\t\t20170520233429_CIT0044","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.3747\/co.v16i0.419","article-title":"Inhibition of mTOR in kidney cancer.","volume":"16 Suppl 1","author":"Kapoor","year":"2009","journal-title":"Curr. Oncol."},{"key":"key\n\t\t\t\t20170520233429_CIT0045","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1038\/nature08109","article-title":"GOLPH3 modulates mTOR signalling and rapamycin sensitivity in cancer.","volume":"459","author":"Scott","year":"2009","journal-title":"Nature"},{"key":"key\n\t\t\t\t20170520233429_CIT0046","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1158\/0008-5472.CAN-06-4490","article-title":"RAD001 (Everolimus) delays tumor onset and progression in a transgenic mouse model of ovarian cancer.","volume":"67","author":"Mabuchi","year":"2007","journal-title":"Cancer Res."},{"key":"key\n\t\t\t\t20170520233429_CIT0047","doi-asserted-by":"crossref","first-page":"5404","DOI":"10.1158\/1078-0432.CCR-09-0365","article-title":"mTOR is a promising therapeutic target both in cisplatin-sensitive and cisplatin-resistant clear cell carcinoma of the ovary.","volume":"15","author":"Mabuchi","year":"2009","journal-title":"Clin. Cancer Res."},{"key":"key\n\t\t\t\t20170520233429_CIT0048","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ygyno.2011.06.022","article-title":"Phase II trial of the mTOR inhibitor, temsirolimus and evaluation of circulating tumor cells and tumor biomarkers in persistent and recurrent epithelial ovarian and primary peritoneal malignancies: a Gynecologic Oncology Group study.","volume":"123","author":"Behbakht","year":"2011","journal-title":"Gynecol. Oncol."},{"key":"key\n\t\t\t\t20170520233429_CIT0049","doi-asserted-by":"crossref","first-page":"2821","DOI":"10.1172\/JCI44203","article-title":"S6 kinase 1 is required for rapamycin-sensitive liver proliferation after mouse hepatectomy.","volume":"121","author":"Espeillac","year":"2011","journal-title":"J. Clin. Invest."},{"key":"key\n\t\t\t\t20170520233429_CIT0050","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1128\/MCB.24.1.200-216.2004","article-title":"mTOR controls cell cycle progression through its cell growth effectors S6K1 and 4E-BP1\/eukaryotic translation initiation factor 4E.","volume":"24","author":"Fingar","year":"2004","journal-title":"Mol. Cell. Biol."},{"key":"key\n\t\t\t\t20170520233429_CIT0051","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1165\/rcmb.2009-0037OC","article-title":"p70 Ribosomal S6 kinase is required for airway smooth muscle cell size enlargement but not increased contractile protein expression.","volume":"42","author":"Deng","year":"2010","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"key\n\t\t\t\t20170520233429_CIT0052","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1101\/gad.995802","article-title":"Mammalian cell size is controlled by mTOR and its downstream targets S6K1 and 4EBP1\/eIF4E.","volume":"16","author":"Fingar","year":"2002","journal-title":"Genes Dev."},{"key":"key\n\t\t\t\t20170520233429_CIT0053","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1038\/ncb1231","article-title":"Atrophy of S6K1(-\/-) skeletal muscle cells reveals distinct mTOR effectors for cell cycle and size control.","volume":"7","author":"Ohanna","year":"2005","journal-title":"Nat. Cell Biol."},{"key":"key\n\t\t\t\t20170520233429_CIT0054","doi-asserted-by":"crossref","first-page":"4106","DOI":"10.4161\/cc.9.20.13630","article-title":"eIF4B controls survival and proliferation and is regulated by proto-oncogenic signaling pathways.","volume":"9","author":"Shahbazian","year":"2010","journal-title":"Cell Cycle"},{"key":"key\n\t\t\t\t20170520233429_CIT0055","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/j.bcp.2012.01.019","article-title":"Inhibition of tumor cell growth, proliferation and migration by X-387, a novel active-site inhibitor of mTOR.","volume":"83","author":"Chen","year":"2012","journal-title":"Biochem. Pharmacol."},{"key":"key\n\t\t\t\t20170520233429_CIT0056","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1517\/14728222.2011.639361","article-title":"The RAS\/RAF\/MEK\/ERK and the PI3K\/AKT signalling pathways: role in cancer pathogenesis and implications for therapeutic approaches.","volume":"16 Suppl 2","author":"De Luca","year":"2012","journal-title":"Expert Opin. Ther. Targets"},{"key":"key\n\t\t\t\t20170520233429_CIT0057","doi-asserted-by":"crossref","first-page":"4378","DOI":"10.1158\/1078-0432.CCR-10-2285","article-title":"Dual mTORC2\/mTORC1 targeting results in potent suppressive effects on acute myeloid leukemia (AML) progenitors.","volume":"17","author":"Altman","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"key\n\t\t\t\t20170520233429_CIT0058","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1158\/0008-5472.CAN-10-3126","article-title":"Reduced VEGF production, angiogenesis, and vascular regrowth contribute to the antitumor properties of dual mTORC1\/mTORC2 inhibitors.","volume":"71","author":"Falcon","year":"2011","journal-title":"Cancer Res."},{"key":"key\n\t\t\t\t20170520233429_CIT0059","doi-asserted-by":"crossref","first-page":"3246","DOI":"10.1158\/0008-5472.CAN-10-4058","article-title":"mTORC1 and mTORC2 regulate EMT, motility, and metastasis of colorectal cancer via RhoA and Rac1 signaling pathways.","volume":"71","author":"Gulhati","year":"2011","journal-title":"Cancer Res."},{"key":"key\n\t\t\t\t20170520233429_CIT0060","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1182\/blood-2011-04-346601","article-title":"Dual mTORC1\/mTORC2 inhibition diminishes Akt activation and induces Puma-dependent apoptosis in lymphoid malignancies.","volume":"119","author":"Gupta","year":"2012","journal-title":"Blood"},{"key":"key\n\t\t\t\t20170520233429_CIT0061","doi-asserted-by":"crossref","first-page":"e20715","DOI":"10.1371\/journal.pone.0020715","article-title":"Mammalian target of rapamycin is a therapeutic target for murine ovarian endometrioid adenocarcinomas with dysregulated Wnt\/\u03b2-catenin and PTEN.","volume":"6","author":"Tanwar","year":"2011","journal-title":"PLoS ONE"}],"container-title":["Carcinogenesis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/carcin\/article-pdf\/33\/11\/2283\/17290535\/bgs263.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,25]],"date-time":"2022-01-25T21:31:45Z","timestamp":1643146305000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/carcin\/article-lookup\/doi\/10.1093\/carcin\/bgs263"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7,27]]},"references-count":61,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2012,7,27]]},"published-print":{"date-parts":[[2012,11]]}},"URL":"https:\/\/doi.org\/10.1093\/carcin\/bgs263","relation":{},"ISSN":["1460-2180","0143-3334"],"issn-type":[{"value":"1460-2180","type":"electronic"},{"value":"0143-3334","type":"print"}],"subject":[],"published":{"date-parts":[[2012,7,27]]}}}